Gene · 3021
NIH grants1,242
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,242
Download this page as JSON| Grant | Title | H3-3B papers | Newest fiscal year |
|---|---|---|---|
| R01CA188228 | Evolution of gliomas during treatment and resistance | 1 | 2025 |
| R01CA198279 | Shaping DNA Damage Response Networks Via Histone H2A Variants | 1 | 2025 |
| R01CA201380 | Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation | 1 | 2025 |
| R01CA207513 | Role of KLHL6 inactivation in mature B-cell malignancies | 1 | 2025 |
| R01CA214799 | Compensatory Mechanisms that Promote Homologous Recombination in BRCA1 Mutant Cancers | 1 | 2025 |
| R01CA218668 | Computational and experimental methods for scalable identification of oncogenic non-coding regions | 1 | 2025 |
| R01CA232425 | The Role of Human RAD52 Protein in Genome Stability | 1 | 2025 |
| R01CA244417 | The role of PARP10 in alleviating replication stress and promoting cellular proliferation and tumorigenesis | 1 | 2025 |
| R01CA255369 | CCL2 and CCR2 as metastatic drivers and therapeutic targets in medulloblastoma | 1 | 2025 |
| R01CA259365 | Structure-activity relationships governing mammalian SWI/SNF chromatin remodeling activity as a function of chromatin state | 1 | 2025 |
| R01CA262316 | Co-Regulation of Alternative Lengthening of Telomeres and Chromatin Dynamics in ATRX-DAXX deficient cancer cells | 1 | 2025 |
| R01CA262466 | Assessing DNA polymerase theta as a therapeutic target in BRCA1 mutant cancer | 1 | 2025 |
| R01CA262815 | Ultrasensitive kinase biosensors for multiplex imaging of coordinated spatiotemporal signaling in cancer-immune interactions | 1 | 2025 |
| R01CA266078 | Histone fold Mutations in Cancer Pathogenesis | 1 | 2025 |
| R01CA266978 | Molecular basis for aberrant de novo DNA methylation in cancer | 1 | 2025 |
| R01CA269977 | Unveiling non-coding drivers of cancer | 1 | 2025 |
| R01DK043806 | Integrative Physiology of Thyroid Hormone Receptors and Nuclear Receptor Corepressors | 1 | 2025 |
| R01ES026184 | The Role of Mono-ADP-Ribosylation by PARP14 in Radioresistance | 1 | 2025 |
| R01EY012200 | Pax6 as a key regulator of lens development | 1 | 2025 |
| R01GM058921 | Histone mRNA Regulation in Development | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3021/grants?page=8